Pramod Sheena, Scheiffele Grant, Huang Wenxi, Parmar Cydney, Guo Yi, Bian Jiang, Guo Serena Jingchuan, Shukla Ashutosh M
Division of Nephrology, Hypertension, and Transplantation, Department of Medicine, University of Florida, Gainesville.
North Florida/South Georgia Veterans Health System, Gainesville, Florida.
JAMA Netw Open. 2025 Sep 2;8(9):e2530972. doi: 10.1001/jamanetworkopen.2025.30972.
Predialysis nephrology care is associated with the likelihood of having a mature, usable arteriovenous access for starting hemodialysis (ie, incident vascular access), a key care quality metric for patients with kidney failure. However, the magnitude of this association has not been quantified to date.
To quantify the attributable association between lack of access to predialysis nephrology care and incident vascular access outcomes among Hispanic patients.
DESIGN, SETTING, AND PARTICIPANTS: This cohort study is a retrospective analysis of the 2021 US Renal Database System. Participants were all adult Medicare recipients initiating hemodialysis between 2010 and 2019; primary analysis was restricted to those with at least 6 months of predialysis Medicare status. Data analysis was performed from June 2022 to November 2024.
Self-reported race and ethnicity, with the non-Hispanic White category serving as the reference and Hispanic ethnicity as the primary comparator. Any predialysis nephrology care was the primary mediator, and at least 6 months of nephrology care and predialysis kidney disease education were the mediators for sensitivity analyses.
The attributable association between predialysis nephrology care and incident vascular access (ie, the composite of arteriovenous fistula [AVF] or arteriovenous graft [AVG]) disparity was the primary outcome, and its attributable association between remaining incident access types, including central venous catheter (CVC) with maturing in-situ AVF or AVG, and CVC without any other access (CVC only) disparity, were the secondary outcomes. Causal mediation analysis with logistic regression was used to determine the unadjusted and adjusted associations.
Among 427 340 eligible patients undergoing incident hemodialysis (mean [SD] age, 72.65 [10.68] years; 241 420 male [56.5%]), 92 887 (21.7%) were Black, 46 146 (10.8%) were Hispanic, 269 697 (63.1%) were White, and 18 610 (4.35%) were other races and ethnicities. AVF was used in 62 075 patients (14.5%), AVG in 13 163 patients (3.1%), and CVC in 351 315 patients (82.2%). Compared with White patients, Hispanic patients had adjusted odds ratios (aORs) of 0.70 (95% CI, 0.68-0.72) for receiving predialysis nephrology care and 0.77 (95% CI, 0.75-0.80) for receiving incident vascular access, for a 23% lower rate. A lack of nephrology care accounted for 32.59% of incident vascular access and 62.00% of maturing vascular access underuse. Sensitivity analyses enhancing the predialysis care disparities strengthened incident vascular access disparity and the attributable association. Secondary analyses revealed that compared with White patients, Hispanic individuals with CVC and a maturing AVF or AVG had 38% (aOR, 1.38; 95% CI, 1.23-1.53) higher odds and those with CVC only had 30% (aOR, 1.30; 95% CI, 1.25-1.35) higher odds of conversion to a functional AVF or AVG within the first year of dialysis, with predialysis care negatively mediating these outcomes.
This retrospective cohort study of incident hemodialysis patients found that system-based disparities in predialysis access to nephrology care contribute to approximately one-third of incident vascular access disparities among Hispanic individuals. Targeted system-based remedies and policies are needed to improve timely identification and nephrology referrals among Hispanic individuals, for equitable improvements in incident kidney failure outcomes.
透析前的肾病护理与建立成熟、可用的动静脉通路以开始血液透析(即新发血管通路)的可能性相关,这是肾衰竭患者护理质量的一项关键指标。然而,迄今为止,这种关联的程度尚未得到量化。
量化西班牙裔患者中无法获得透析前肾病护理与新发血管通路结局之间的归因关联。
设计、设置和参与者:这项队列研究是对2021年美国肾脏数据库系统的回顾性分析。参与者为2010年至2019年间开始接受血液透析的所有成年医疗保险受益患者;主要分析仅限于那些透析前医疗保险状态至少为6个月的患者。数据分析于2022年6月至2024年11月进行。
自我报告的种族和族裔,以非西班牙裔白人作为对照,西班牙裔族裔作为主要比较对象。任何透析前的肾病护理是主要中介因素,至少6个月的肾病护理和透析前肾病教育是敏感性分析的中介因素。
透析前肾病护理与新发血管通路(即动静脉内瘘[AVF]或动静脉移植物[AVG]的组合)差异之间的归因关联是主要结局,其与其余新发通路类型之间的归因关联,包括中心静脉导管(CVC)与原位成熟的AVF或AVG,以及无任何其他通路的CVC(仅CVC)差异,是次要结局。采用逻辑回归的因果中介分析来确定未调整和调整后的关联。
在427340例符合条件的接受新发血液透析的患者中(平均[标准差]年龄,72.65[10.68]岁;241420例男性[56.5%]),92887例(21.7%)为黑人,46146例(10.8%)为西班牙裔,269697例(63.1%)为白人,18610例(4.35%)为其他种族和族裔。62075例患者(14.5%)使用AVF,13163例患者(3.1%)使用AVG,351315例患者(82.2%)使用CVC。与白人患者相比,西班牙裔患者接受透析前肾病护理的调整后比值比(aOR)为0.70(95%置信区间,0.68 - 0.72),接受新发血管通路的aOR为0.77(95%置信区间,0.75 - 0.80),发生率低23%。缺乏肾病护理占新发血管通路的32.59%,占成熟血管通路未充分利用的62.00%。增强透析前护理差异的敏感性分析强化了新发血管通路差异和归因关联。次要分析显示,与白人患者相比,使用CVC且有成熟AVF或AVG的西班牙裔个体在透析的第一年内转换为功能性AVF或AVG的几率高38%(aOR,1.38;95%置信区间,1.23 - 1.53),仅使用CVC的个体高30%(aOR,1.30;95%置信区间,1.25 - 1.35),透析前护理对这些结局起负向中介作用。
这项对新发血液透析患者的回顾性队列研究发现,透析前获得肾病护理方面基于系统的差异导致西班牙裔个体中约三分之一的新发血管通路差异。需要有针对性的基于系统的补救措施和政策,以改善西班牙裔个体中及时识别和肾病转诊情况,从而公平地改善新发肾衰竭结局。